Summit Therapeutics Inc. (SMMT)
NASDAQ: SMMT · Real-Time Price · USD
25.26
+1.30 (5.43%)
At close: May 12, 2025, 4:00 PM
25.16
-0.10 (-0.40%)
After-hours: May 12, 2025, 7:07 PM EDT

Summit Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Operating Revenue
---0.711.810.86
Upgrade
Revenue
---0.711.810.86
Upgrade
Revenue Growth (YoY)
----61.03%110.35%6.10%
Upgrade
Gross Profit
---0.711.810.86
Upgrade
Selling, General & Admin
64.660.5330.2726.7423.6119.23
Upgrade
Research & Development
171.17150.7859.475285.3553.27
Upgrade
Other Operating Expenses
-0.31-0.31-1-14.42-20.97-19.31
Upgrade
Operating Expenses
235.45210.9988.7464.338853.19
Upgrade
Operating Income
-235.45-210.99-88.74-63.62-86.19-52.33
Upgrade
Interest Expense
-5.57-8.69-16.46-4.4-0.24-0.26
Upgrade
Interest & Investment Income
15.513.4710.41.51-0
Upgrade
Currency Exchange Gain (Loss)
-0.23-0.11.03-4.11-2.140.05
Upgrade
Other Non Operating Income (Expenses)
---0.250.3-0.040.48
Upgrade
EBT Excluding Unusual Items
-225.75-206.31-94.01-70.31-88.6-52.05
Upgrade
Asset Writedown
----8.47--0.86
Upgrade
Pretax Income
-240.76-221.32-614.93-78.78-88.6-52.91
Upgrade
Income Tax Expense
------0.21
Upgrade
Net Income
-240.76-221.32-614.93-78.78-88.6-52.7
Upgrade
Net Income to Common
-240.76-221.32-614.93-78.78-88.6-52.7
Upgrade
Shares Outstanding (Basic)
7287196201939270
Upgrade
Shares Outstanding (Diluted)
7287196201939270
Upgrade
Shares Change (YoY)
3.86%15.96%220.50%109.60%32.67%111.78%
Upgrade
EPS (Basic)
-0.33-0.31-0.99-0.41-0.96-0.76
Upgrade
EPS (Diluted)
-0.34-0.31-0.99-0.41-0.96-0.76
Upgrade
Free Cash Flow
-173.7-142.25-76.89-42.21-72.89-48.53
Upgrade
Free Cash Flow Per Share
-0.24-0.20-0.12-0.22-0.79-0.70
Upgrade
Gross Margin
---100.00%100.00%100.00%
Upgrade
Operating Margin
----9024.25%-4764.29%-6085.35%
Upgrade
Profit Margin
----11174.75%-4897.84%-6127.56%
Upgrade
Free Cash Flow Margin
----5986.67%-4029.46%-5643.26%
Upgrade
EBITDA
-235.37-210.9-88.54-62.36-84.84-50.78
Upgrade
D&A For EBITDA
0.090.090.21.261.351.55
Upgrade
EBIT
-235.45-210.99-88.74-63.62-86.19-52.33
Upgrade
Updated May 1, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q